| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.0067 | 0.8 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.0065 | 0.8 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.0064 | 0.8 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.8 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.8 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.0063 | 0.8 |